Please login to the form below

Not currently logged in


This page shows the latest Paxlovid news and features for those working in and with pharma, biotech and healthcare.

Annual COVID-19 jabs likely, says Pfizer head

Annual COVID-19 jabs likely, says Pfizer head

Bourla also pointed to high effectiveness of its antiviral drug Paxlovid, which cut hospital admissions and deaths by nearly 90% in trials.

Latest news

  • US regulators set to approve oral antiviral against COVID-19 US regulators set to approve oral antiviral against COVID-19

    The FDA looks set to authorise Merck’s molnupiravir after its advisory body recommended the antiviral treatment, while Pfizer’s Paxlovid may be next. ... The recommendation to the FDA clears the way for a second oral antiviral, Pfizer’s Paxlovid,

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Virtual meeting technologies for reducing emissions and waste in the healthcare industry
Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...